Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.72
Delayed Data
As of May 22
 -0.03 / -4.00%
Today’s Change
0.65
Today|||52-Week Range
1.04
+2.86%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close0.75
Today’s open0.76
Day’s range0.72 - 0.76
Volume1,011,640
Average volume (3 months)572,297
Market cap$134.7M
Dividend yield--
Data as of 4:02pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)-57.14%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book5.03

Competitors

 Today’s
change
Today’s
% change
SMMTSummit Therapeutics ...+0.18+1.64%
ADHDAlcobra Ltd+0.21+3.34%
EPRSEPIRUS Biopharmaceut...-0.07-1.25%
LPCNLipocine Inc0.000.00%
Data as of 4:00pm ET, 05/22/2015

Financials

Last reporting dateMay 11, 2015
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$0.00
Annual profit (last year)-$18.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Scientist
Chang Ho Ahn
Chief Executive Officer &
Director
Peter David Suzdak
Corporate headquarters
Rockville, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers